← Back to Search

Monoclonal Antibodies

Intermediate Risk for Hodgkin's Lymphoma

Phase 2
Waitlist Available
Led By Jessica Hochberg, MD
Research Sponsored by Mitchell Cairo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial found that adding Bv to chemotherapy will be safe and effective for young HL patients.

Eligible Conditions
  • Hodgkin's Lymphoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To determine if this combination of chemoimmunotherapy is safe to administer. (Adverse events)
To determine the response rate

Trial Design

3Treatment groups
Experimental Treatment
Group I: Low RiskExperimental Treatment3 Interventions
Low Risk Patients (Stage IA, IIA; no bulky disease or extension): 3 cycles of chemotherapy
Group II: Intermediate RiskExperimental Treatment4 Interventions
Intermediate Risk Patients (Stage IA bulk/E, IB, IIA bulk/E, IIB, IIIA): 4 cycles of chemotherapy
Group III: High RiskExperimental Treatment4 Interventions
High Risk Patients (Stage IIIA bulk/ E, IIIB, IVA/B): 6 cycles of chemotherapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Brentuximab Vedotin
2015
Completed Phase 3
~1080
Doxorubicin
2012
Completed Phase 3
~8030
Vincristine
2003
Completed Phase 4
~2970
Rituximab
1999
Completed Phase 4
~2200

Find a Location

Who is running the clinical trial?

Mitchell CairoLead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Jessica Hochberg, MDPrincipal InvestigatorNew York Medical College
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top